Page last updated: 2024-08-21

isoxazoles and Cruveilhier-Baumgarten Syndrome

isoxazoles has been researched along with Cruveilhier-Baumgarten Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alawad, AS; Levy, C1
Burnet, M; Deuschle, U; Garnys, L; Hambruch, E; Hayden, H; Kremoser, C; Mitteregger, D; Oberhuber, G; Peck-Radosavljevic, M; Podesser, BK; Reiberger, T; Riedl, F; Rohr-Udilova, N; Schubert, TL; Schwabl, P; Seeland, BA; Starlinger, P; Strobel, B; Trauner, M; Wagner, M1
Cima, K; Desole, S; Graziadei, I; Kähler, CM; Vogel, W; Vogelsinger, H1

Reviews

1 review(s) available for isoxazoles and Cruveilhier-Baumgarten Syndrome

ArticleYear
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:12

    Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid

2016

Other Studies

2 other study(ies) available for isoxazoles and Cruveilhier-Baumgarten Syndrome

ArticleYear
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.
    Journal of hepatology, 2017, Volume: 66, Issue:4

    Topics: Animals; Benzoates; Bile Acids and Salts; Bilirubin; Capillaries; Cholesterol; Disease Models, Animal; Hypertension, Portal; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Vascular Remodeling; Vascular Resistance

2017
Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.
    Wiener klinische Wochenschrift, 2011, Volume: 123, Issue:7-8

    Topics: Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Isoxazoles; Male; Pilot Projects; Syndrome; Thiophenes; Treatment Outcome; Young Adult

2011